133 related articles for article (PubMed ID: 38316550)
1. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
Sato T; Furukawa T; Teramachi R; Fukihara J; Yamano Y; Yokoyama T; Matsuda T; Kataoka K; Kimura T; Sakamoto K; Ishii M; Kondoh Y
Thorax; 2024 Apr; 79(5):422-429. PubMed ID: 38316550
[TBL] [Abstract][Full Text] [Related]
2. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
Karia N; Howard L; Johnson M; Kiely DG; Lordan J; McCabe C; Pepke-Zaba J; Ong R; Preiss M; Knight D; Muthurangu V; Coghlan JG
Eur Heart J; 2023 Nov; 44(44):4678-4691. PubMed ID: 37619574
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.
Maron BA; Brittain EL; Hess E; Waldo SW; Barón AE; Huang S; Goldstein RH; Assad T; Wertheim BM; Alba GA; Leopold JA; Olschewski H; Galiè N; Simonneau G; Kovacs G; Tedford RJ; Humbert M; Choudhary G
Lancet Respir Med; 2020 Sep; 8(9):873-884. PubMed ID: 32730752
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.
Piccari L; Wort SJ; Meloni F; Rizzo M; Price LC; Martino L; Salvaterra E; Scelsi L; López Meseguer M; Blanco I; Callari A; Pérez González V; Tuzzolino F; McCabe C; Rodríguez Chiaradía DA; Vitulo P;
Respiration; 2022; 101(8):717-727. PubMed ID: 35462365
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension.
Corte TJ; Wort SJ; Gatzoulis MA; Macdonald P; Hansell DM; Wells AU
Thorax; 2009 Oct; 64(10):883-8. PubMed ID: 19546096
[TBL] [Abstract][Full Text] [Related]
6. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
7. Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality.
Puigrenier S; Giovannelli J; Lamblin N; De Groote P; Fertin M; Bervar JF; Lamer A; Edmé JL; Balquet MH; Sobanski V; Launay D; Hachulla É; Sanges S
Respir Res; 2022 Oct; 23(1):284. PubMed ID: 36243869
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
9. Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile.
Crawford TC; Leary PJ; Fraser CD; Suarez-Pierre A; Magruder JT; Baumgartner WA; Zehr KJ; Whitman GJ; Masri SC; Sheikh F; De Marco T; Maron BA; Sharma K; Gilotra NA; Russell SD; Houston BA; Ramu B; Tedford RJ
Chest; 2020 Jan; 157(1):151-161. PubMed ID: 31446063
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
Awerbach JD; Stackhouse KA; Lee J; Dahhan T; Parikh KS; Krasuski RA
Respir Med; 2019 Apr; 150():126-130. PubMed ID: 30961938
[TBL] [Abstract][Full Text] [Related]
12. Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.
Nemoto K; Oh-Ishi S; Akiyama T; Yabuuchi Y; Goto H; Nonaka M; Sasatani Y; Tachi H; Arai N; Ishikawa H; Hyodo K; Hase I; Miura Y; Takaku T; Hayashihara K; Saito T
BMC Pulm Med; 2019 Sep; 19(1):167. PubMed ID: 31477076
[TBL] [Abstract][Full Text] [Related]
13. Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.
Sharma S; Ruiz J; Paghdar S; Desai S; Goswami R
Transplant Proc; 2023 Dec; 55(10):2462-2469. PubMed ID: 37980253
[TBL] [Abstract][Full Text] [Related]
14. Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis.
Gayen SK; Zulty M; Criner GJ
Respir Res; 2024 Feb; 25(1):79. PubMed ID: 38321451
[TBL] [Abstract][Full Text] [Related]
15. Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.
Suzuki A; Taniguchi H; Watanabe N; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Nishiyama O; Hasegawa Y
PLoS One; 2014; 9(9):e108339. PubMed ID: 25268705
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation.
Dotan Y; Stewart J; Gangemi A; Wang H; Aneja A; Chakraborty B; Dass C; Zhao H; Marchetti N; D'Alonzo G; Cordova FC; Criner G; Mamary AJ
BMJ Open Respir Res; 2020 Jul; 7(1):. PubMed ID: 32661103
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.
Swift AJ; Rajaram S; Hurdman J; Hill C; Davies C; Sproson TW; Morton AC; Capener D; Elliot C; Condliffe R; Wild JM; Kiely DG
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1036-1047. PubMed ID: 23769494
[TBL] [Abstract][Full Text] [Related]
18. Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation.
Sultan I; Fukui M; Bianco V; Brown JA; Kliner DE; Hickey G; Thoma FW; Lee JS; Schindler JT; Kilic A; Gleason TG; Cavalcante JL
Am J Cardiol; 2020 Sep; 131():60-66. PubMed ID: 32713655
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease.
Yasui K; Yuda S; Abe K; Muranaka A; Otsuka M; Ohnishi H; Hashimoto A; Takahashi H; Tsuchihashi K; Takahashi H; Takahashi S; Miura T
J Cardiol; 2016 Oct; 68(4):300-7. PubMed ID: 27032318
[TBL] [Abstract][Full Text] [Related]
20. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Maron BA; Hess E; Maddox TM; Opotowsky AR; Tedford RJ; Lahm T; Joynt KE; Kass DJ; Stephens T; Stanislawski MA; Swenson ER; Goldstein RH; Leopold JA; Zamanian RT; Elwing JM; Plomondon ME; Grunwald GK; Barón AE; Rumsfeld JS; Choudhary G
Circulation; 2016 Mar; 133(13):1240-8. PubMed ID: 26873944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
